| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special Article |
From Case Western Reserve University (E.M.C., C.L.), Cleveland, Ohio; the Division of Hematology (S.P.S., R.H.A.), University of Colorado Health Sciences Center, Denver; the Division of Gastroenterology and Hepatology (A.T.), University Medical Center Nijmegen, Nijmegen, the Netherlands; the Department of Biochemistry (C.W.), Vanderbilt University and the Department of Veterans Affairs Medical Center, Nashville, Tenn; the Department of Nutrition (S.H.Z.), School of Public Health and School of Medicine, University of North Carolina, Chapel Hill; and the Laboratory of Molecular Biology (S.H.M.), National Institute of Mental Health, Bethesda, Md.
Correspondence to S. Harvey Mudd, MD, NIMH/DIRP/LMB, Bldg 36, Room 1B-08, 36 Convent Dr MSC 4034, Bethesda, MD 20892-4034. E-mail shm{at}codon.nih.gov
Abstract
Abstract The death of a control subject after an oral load of methionine for a study of the possible relationship between homocysteine and Alzheimers disease is reported. The subject developed postload plasma concentrations of methionine far beyond those reported previously in humans given the usual oral loading dose of methionine (100 mg/kg body wt). Her preload plasma metabolite values rule out known genetic diseases that might predispose one to unusually high methionine concentrations. The most likely explanation for these events is that the subject received a substantial overdose of methionine. The possibility that extremely high methionine concentrations may lead to severe cerebral effects is discussed, and it is recommended that any move to increase the sensitivity of the usual methionine loading test by increasing the dose of methionine either not be undertaken or be taken only with extreme care.
Key Words: methionine load elevation cerebral death
This article has been cited by other articles:
![]() |
P. B. Pencharz, R. Elango, and R. O. Ball An Approach to Defining the Upper Safe Limits of Amino Acid Intake J. Nutr., October 1, 2008; 138(10): 1996S - 2002S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dayal and S. R. Lentz Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1596 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Garlick Toxicity of Methionine in Humans J. Nutr., June 1, 2006; 136(6): 1722S - 1725S. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Young Introduction to the 3rd Amino Acid Assessment Workshop J. Nutr., June 1, 2004; 134(6): 1555S - 1557S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sakai, M. Miura, M. Amao, R. Kodama, S. Toue, Y. Noguchi, and T. Kimura Potential Approaches to the Assessment of Amino Acid Adequacy in Rats: A Progress Report J. Nutr., June 1, 2004; 134(6): 1651S - 1655S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Levine, R. Faden, C. Grady, D. Hammerschmidt, L. Eckenwiler, J. Sugarman, and on behalf of the Consortium to Examine Clinical Re "Special Scrutiny": A Targeted Form of Research Protocol Review Ann Intern Med, February 3, 2004; 140(3): 220 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Young Introduction to the 2nd Amino Acid Assessment Workshop J. Nutr., June 1, 2003; 133(6): 2015S - 2020. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |